$Kazia Therapeutics (KZIA.US)$ Kazia Therapeutics and the Hebrew University of Jerusalem Receives a Grant from The Michael J. Fox Foundation to Evaluate the Therapeutic Potential of Paxalisib as a Treatment for Parkinson's Disease Thursday, 20th February at 8:46 am SYDNEY, Feb. 20, 2025 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia" or "the Company"), an oncology-focused drug development company, today announced a research grant awarded from The Michael J. Fox Foundation f...
$Kazia Therapeutics (KZIA.US)$ On February 3, 2025, Kazia Therapeutics updated its corporate presentation to highlight its ongoing efforts in oncology drug development, particularly with its key assets, paxalisib and EVT801. The company is actively conducting clinical trials across multiple cancer types, including glioblastoma and advanced solid tumors, and has received various FDA designations for its innovative approaches. This update underscores Kazia’s strategic position in the oncol...
Kazia Therapeutics Stock Forum
Can This Brain-Penetrating Drug Breakthrough Transform Parkinson's Treatment? Major Foundation Thinks So
Kazia Therapeutics and the Hebrew University of Jerusalem Receives a Grant from The Michael J. Fox Foundation to Evaluate the Therapeutic Potential of Paxalisib as a Treatment for Parkinson's Disease
Thursday, 20th February at 8:46 am
SYDNEY, Feb. 20, 2025 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia" or "the Company"), an oncology-focused drug development company, today announced a research grant awarded from The Michael J. Fox Foundation f...
what a garbage stock
On February 3, 2025, Kazia Therapeutics updated its corporate presentation to highlight its ongoing efforts in oncology drug development, particularly with its key assets, paxalisib and EVT801. The company is actively conducting clinical trials across multiple cancer types, including glioblastoma and advanced solid tumors, and has received various FDA designations for its innovative approaches. This update underscores Kazia’s strategic position in the oncol...
$Alpha Modus Holdings (AMOD.US)$
don’t expect any further price increase today, it’s a sell..
No comment yet